Ina A. Eilertsen

2.5k total citations · 1 hit paper
26 papers, 1.7k citations indexed

About

Ina A. Eilertsen is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Ina A. Eilertsen has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 17 papers in Cancer Research and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Ina A. Eilertsen's work include Cancer Genomics and Diagnostics (14 papers), Genetic factors in colorectal cancer (14 papers) and Colorectal Cancer Treatments and Studies (13 papers). Ina A. Eilertsen is often cited by papers focused on Cancer Genomics and Diagnostics (14 papers), Genetic factors in colorectal cancer (14 papers) and Colorectal Cancer Treatments and Studies (13 papers). Ina A. Eilertsen collaborates with scholars based in Norway, Sweden and Finland. Ina A. Eilertsen's co-authors include Ragnhild A. Lothe, Peter W. Eide, Stine A. Danielsen, Guro E. Lind, Merete Hektoen, M. Eknæs, Anita Sveen, Arild Nesbakken, Jarle Bruun and Kaja C. G. Berg and has published in prestigious journals such as Nature Communications, Cancer Research and Clinical Cancer Research.

In The Last Decade

Ina A. Eilertsen

24 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetic and genetic features of 24 colon cancer cell lines

2013 682 citations Peter W. Eide, Ina A. Eilertsen et al. Oncogenesis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ina A. Eilertsen Norway	16	943	784	498	387	186	26	1.7k
Peter W. Eide Norway	14	1.1k 1.2×	843 1.1×	615 1.2×	408 1.1×	187 1.0×	19	2.0k
Anna Martínez‐Cardús Spain	23	1.3k 1.3×	813 1.0×	487 1.0×	221 0.6×	189 1.0×	48	1.9k
Eva Martinez‐Balibrea Spain	20	937 1.0×	898 1.1×	399 0.8×	237 0.6×	209 1.1×	43	1.7k
Jarle Bruun Norway	21	1.2k 1.3×	890 1.1×	608 1.2×	334 0.9×	337 1.8×	32	2.1k
Merete Hektoen Norway	14	739 0.8×	592 0.8×	402 0.8×	386 1.0×	228 1.2×	22	1.5k
Wendy L. Allen United Kingdom	20	929 1.0×	754 1.0×	326 0.7×	277 0.7×	176 0.9×	39	1.6k
Pat Gulhati United States	15	1.3k 1.4×	550 0.7×	455 0.9×	206 0.5×	224 1.2×	33	1.9k
Ahmed A. Samatar United States	14	1.3k 1.4×	629 0.8×	249 0.5×	229 0.6×	141 0.8×	31	1.7k
Amro Aboukameel United States	31	2.0k 2.1×	1.0k 1.3×	611 1.2×	226 0.6×	166 0.9×	91	2.8k
Mina Maftouh Iran	26	1.2k 1.3×	648 0.8×	752 1.5×	204 0.5×	189 1.0×	39	1.9k

Countries citing papers authored by Ina A. Eilertsen

Since Specialization

Citations

This map shows the geographic impact of Ina A. Eilertsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina A. Eilertsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina A. Eilertsen more than expected).

Fields of papers citing papers by Ina A. Eilertsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina A. Eilertsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina A. Eilertsen. The network helps show where Ina A. Eilertsen may publish in the future.

Co-authorship network of co-authors of Ina A. Eilertsen

This figure shows the co-authorship network connecting the top 25 collaborators of Ina A. Eilertsen. A scholar is included among the top collaborators of Ina A. Eilertsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina A. Eilertsen. Ina A. Eilertsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergsland, Christian H., Anita Sveen, Jarle Bruun, et al.. (2024). The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration. Cellular Oncology. 47(4). 1267–1276. 6 indexed citations

Eilertsen, Ina A., Henrik M. Reims, Merete Hektoen, et al.. (2024). Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer. Nature Communications. 15(1). 4342–4342. 4 indexed citations

Høland, Maren, Kaja C. G. Berg, Ina A. Eilertsen, et al.. (2023). Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets. EBioMedicine. 97. 104829–104829. 10 indexed citations

Eide, Peter W., Ina A. Eilertsen, Kaja C. G. Berg, et al.. (2021). De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity. Genome Medicine. 13(1). 143–143. 21 indexed citations

Eide, Peter W., Ina A. Eilertsen, Kaja C. G. Berg, et al.. (2021). Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer. npj Genomic Medicine. 6(1). 59–59. 38 indexed citations

Sveen, Anita, Bjarne Johannessen, Ina A. Eilertsen, et al.. (2021). The expressed mutational landscape of microsatellite stable colorectal cancers. Genome Medicine. 13(1). 142–142. 4 indexed citations

Kryeziu, Kushtrim, Kaja C. G. Berg, Ina A. Eilertsen, et al.. (2020). Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity. EBioMedicine. 59. 102923–102923. 27 indexed citations

Sveen, Anita, Christian H. Bergsland, Ina A. Eilertsen, et al.. (2019). Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer. ESMO Open. 4(3). e000523–e000523. 13 indexed citations

Eilertsen, Ina A., et al.. (2019). Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer. Cancer Letters. 469. 246–255. 15 indexed citations

10.

Sveen, Anita, Ina A. Eilertsen, Stine A. Danielsen, et al.. (2019). Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer. Oncogenesis. 8(6). 35–35. 21 indexed citations

11.

Sveen, Anita, Marianne A. Merok, Stine A. Danielsen, et al.. (2018). CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer. Annals of Oncology. 29(5). 1227–1234. 63 indexed citations

12.

Høland, Maren, Matthias Kolberg, Stine A. Danielsen, et al.. (2018). Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53. Modern Pathology. 31(11). 1694–1707. 12 indexed citations

13.

Sveen, Anita, Jarle Bruun, Peter W. Eide, et al.. (2017). Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies. Clinical Cancer Research. 24(4). 794–806. 173 indexed citations

14.

Sveen, Anita, Christian H. Bergsland, Marianne A. Merok, et al.. (2017). Prognostic impact of BRAF and KRAS mutations according to the consensus molecular subtypes of colorectal cancer. Annals of Oncology. 28. v186–v186.

15.

Sveen, Anita, Bjarne Johannessen, Torstein Tengs, et al.. (2017). Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1. Genome Medicine. 9(1). 46–46. 66 indexed citations

16.

Berg, Kaja C. G., Peter W. Eide, Ina A. Eilertsen, et al.. (2017). Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. Molecular Cancer. 16(1). 116–116. 284 indexed citations

17.

Kolberg, Matthias, Jarle Bruun, Astrid Murumägi, et al.. (2017). Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors. Molecular Oncology. 11(9). 1156–1171. 16 indexed citations

18.

Carvalho, Joäo, Lina Cekaite, Anita Sveen, et al.. (2016). Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1. Cancer Letters. 385. 150–159. 55 indexed citations

19.

Eide, Peter W., Ina A. Eilertsen, Stine A. Danielsen, et al.. (2013). Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2(9). e71–e71. 682 indexed citations breakdown →

20.

Eide, Peter W., Lina Cekaite, Stine A. Danielsen, et al.. (2012). NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway. Cellular Signalling. 25(1). 12–18. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact